• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子表达与肿瘤血管形成及人类胃癌患者预后的相关性

Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.

作者信息

Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T

机构信息

Second Department of Surgery, Fukui Medical School, Japan.

出版信息

J Clin Oncol. 1997 Feb;15(2):826-32. doi: 10.1200/JCO.1997.15.2.826.

DOI:10.1200/JCO.1997.15.2.826
PMID:9053510
Abstract

PURPOSE

The relationship between the expression of vascular endothelial growth factor (VEGF) and its receptor, KDR, in human gastric carcinoma tissues and tumor angiogenesis, as well as patient outcome, were investigated.

MATERIALS AND METHODS

One hundred sixty-three primary tumor specimens were investigated by immunohistochemical studies with anti-VEGF, anti-KDR, and anti-CD34 antibodies and by monitoring patients for at least 2 years after surgery.

RESULTS

For intensity of VEGF staining, 48 tumors were graded as 0, 36 as 1+, 63 as 2+, and 16 as 3+. Tumors with strong VEGF staining, assessed as 2+ and 3+, had significantly higher vascularity than those with weak VEGF. Eighty-eight tumors (54%) were positive for KDR. There was no association between KDR expression and tumor vascularity. No close correlation was found between VEGF and KDR expressions. The Cox proportional hazards model identified intratumoral vessel count as the most significant and independent prognostic factor among various clinicopathologic factors. In contrast, overall survival rates for 84 patients with weak VEGF staining tumors and 79 with strong VEGF staining tumors were not significantly different. Patients with tumors of either localized Borrmann types or well-differentiated histologies, which are found more frequently in tumors with strong VEGF staining, survived significantly longer than those with tumors of either infiltrative Borrmann types or poorly differentiated histologies.

CONCLUSION

We suggest that expression of VEGF is more frequently found in tumors with well-differentiated histology and plays a role in the promotion of angiogenesis in human gastric carcinomas.

摘要

目的

研究血管内皮生长因子(VEGF)及其受体KDR在人胃癌组织中的表达与肿瘤血管生成以及患者预后之间的关系。

材料与方法

采用抗VEGF、抗KDR和抗CD34抗体的免疫组织化学研究方法,对163例原发性肿瘤标本进行检测,并对患者术后至少随访2年。

结果

对于VEGF染色强度,48例肿瘤评分为0级,36例为1+级,63例为2+级,16例为3+级。VEGF染色强(评分为2+和3+)的肿瘤血管密度明显高于VEGF染色弱的肿瘤。88例肿瘤(54%)KDR呈阳性。KDR表达与肿瘤血管密度之间无关联。VEGF和KDR表达之间未发现密切相关性。Cox比例风险模型确定肿瘤内血管计数是各种临床病理因素中最显著且独立的预后因素。相比之下,84例VEGF染色弱的肿瘤患者和79例VEGF染色强的肿瘤患者的总生存率无显著差异。VEGF染色强的肿瘤中更常见的局限性Borrmann型或高分化组织学类型的肿瘤患者,其生存期明显长于浸润性Borrmann型或低分化组织学类型的肿瘤患者。

结论

我们认为VEGF更常见于高分化组织学类型的肿瘤中,并在人胃癌血管生成促进中发挥作用。

相似文献

1
Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.血管内皮生长因子表达与肿瘤血管形成及人类胃癌患者预后的相关性
J Clin Oncol. 1997 Feb;15(2):826-32. doi: 10.1200/JCO.1997.15.2.826.
2
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.血管内皮生长因子及其受体KDR的表达与人类结肠癌的血管生成、转移及增殖相关。
Cancer Res. 1995 Sep 15;55(18):3964-8.
3
VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.血管内皮生长因子(VEGF)、fms样酪氨酸激酶-1(flt-1)和激酶插入区受体/胎儿肝脏激酶-1(KDR/flk-1)作为子宫内膜癌的预后指标
Gynecol Oncol. 2000 Jan;76(1):33-9. doi: 10.1006/gyno.1999.5658.
4
Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.血管计数及血管内皮生长因子及其受体(KDR)在肠型胃癌中的意义
Clin Cancer Res. 1996 Oct;2(10):1679-84.
5
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.血管通透性因子(血管内皮生长因子)及其受体在子宫内膜癌中的表达
Cancer. 1996 Aug 1;78(3):454-60. doi: 10.1002/(SICI)1097-0142(19960801)78:3<454::AID-CNCR12>3.0.CO;2-Y.
6
Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer.血管内皮生长因子及其受体KDR(含激酶结构域受体)/Flk-1(胎儿肝激酶-1)的表达作为人类结直肠癌的预后因素
Int J Clin Oncol. 2001 Oct;6(5):221-8. doi: 10.1007/pl00012109.
7
Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.血管内皮生长因子(VEGF)及其两种特异性受体Flt-1和KDR在猪胎盘和非妊娠子宫中的免疫组织化学定位。
Placenta. 1999 Jan;20(1):35-43. doi: 10.1053/plac.1998.0350.
8
The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.子宫内膜癌患者中血管生成的“血管内皮生长因子/flk-1(KDR)受体”通路:预后及治疗意义
Cancer. 2001 Nov 15;92(10):2569-77. doi: 10.1002/1097-0142(20011115)92:10<2569::aid-cncr1609>3.0.co;2-3.
9
Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.血管内皮生长因子及其受体在与冯·希佩尔-林道病相关的和散发性血管母细胞瘤中的上调。
Cancer Res. 1995 Mar 15;55(6):1358-64.
10
Co-localization of vascular endothelial growth factor and its two receptors flt-1 and kdr in the mink placenta.血管内皮生长因子及其两种受体flt-1和kdr在水貂胎盘内的共定位
Placenta. 2001 May;22(5):457-65. doi: 10.1053/plac.2001.0655.

引用本文的文献

1
Immunotherapy in gastric cancer with liver metastasis: Challenges and opportunities.胃癌肝转移的免疫治疗:挑战与机遇
World J Gastrointest Surg. 2024 Jun 27;16(6):1513-1516. doi: 10.4240/wjgs.v16.i6.1513.
2
Identification of differentially expressed mRNAs as novel predictive biomarkers for gastric cancer diagnosis and prognosis.鉴定差异表达的mRNA作为胃癌诊断和预后的新型预测生物标志物。
World J Gastrointest Oncol. 2024 May 15;16(5):1947-1964. doi: 10.4251/wjgo.v16.i5.1947.
3
Clinical efficacy of PD-1 inhibitor combined with radiotherapy in a multi-drug resistant patient with liver metastasis from gastric cancer.
PD-1抑制剂联合放疗对一名胃癌肝转移多药耐药患者的临床疗效
Front Surg. 2023 Apr 20;10:1101294. doi: 10.3389/fsurg.2023.1101294. eCollection 2023.
4
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer.抗血管内皮生长因子(VEGF)药物研发的传承:通过打破癌症血管生成的恶性循环来提高研发成功率
Cancers (Basel). 2021 Jul 8;13(14):3433. doi: 10.3390/cancers13143433.
5
Chemopreventive Effect of Metformin on Gastric Cancer Development.二甲双胍在胃癌发展中的化学预防作用。
Gut Liver. 2022 Mar 15;16(2):147-156. doi: 10.5009/gnl210132.
6
Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.基于基因组规模分析鉴定 NID2、SPARC 和 MFAP2 作为胃癌总生存的预后标志物。
Med Sci Monit. 2021 Mar 24;27:e929558. doi: 10.12659/MSM.929558.
7
Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.全基因组信使 RNA 谱分析鉴定出一种新的预测胃癌生存的特征。
Clin Transl Gastroenterol. 2019 Jan;10(1):e00004. doi: 10.14309/ctg.0000000000000004.
8
Postoperative Infectious Complications Impact Long-Term Survival in Patients Who Underwent Hepatectomies for Colorectal Liver Metastases: a Propensity Score Matching Analysis.术后感染并发症影响接受肝切除术治疗结直肠癌肝转移患者的长期生存:倾向评分匹配分析。
J Gastrointest Surg. 2018 Dec;22(12):2045-2054. doi: 10.1007/s11605-018-3854-2. Epub 2018 Jul 10.
9
VEGFA and VEGFR2 RNAscope determination in gastric cancer.胃癌中 VEGFA 和 VEGFR2 RNAscope 的测定。
J Mol Histol. 2018 Aug;49(4):429-435. doi: 10.1007/s10735-018-9777-0. Epub 2018 May 14.
10
Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.治疗前中性粒细胞与淋巴细胞比值:肝细胞癌中有用的预后生物标志物。
J Hepatocell Carcinoma. 2018 Jan 18;5:17-28. doi: 10.2147/JHC.S86792. eCollection 2018.